St. Peter, Austria

Sabine Stummfoll


Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2003-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Sabine Stummfoll in Allergen Research

Introduction

Sabine Stummfoll, an innovative inventor based in St. Peter, Austria, has made significant contributions to the field of allergen research. With three registered patents, her work primarily focuses on hypoallergenic immunogenic molecules derived from grass pollen allergens, particularly Phl p 6. Her inventions aim to enhance the safety and efficacy of allergy treatments.

Latest Patents

Sabine's latest patents center on non-anaphylactic forms of the grass pollen Phl p 6 allergen. One of her notable inventions introduces a hypoallergenic immunogenic molecule that possesses an N-terminal and/or C-terminal deletion, ensuring that it substantially lacks IgE binding capacity. This transformative approach not only provides a means for hyposensitization but also serves as a diagnostic tool. Furthermore, her work includes a combination of two different Phl p 6 molecules, each lacking IgE binding, which together encompass the complete sequence of Phl p 6.

Career Highlights

Throughout her career, Sabine has showcased her passion for research and innovation. She has held meaningful positions at various companies, including Phadia AB, where she provided valuable insights into allergen science and technology. Her contributions are driven by a desire to improve the lives of individuals affected by allergies.

Collaborations

Sabine has collaborated with distinguished peers, including Rudolf Valenta and Susanne Vrtala. Working alongside other experts in the field has propelled her research and has contributed to significant advancements in hypoallergenic immunogenic molecules.

Conclusion

Sabine Stummfoll's inventive spirit and dedication to allergen research exemplify the impactful role of scientists and inventors in addressing health challenges. Her work not only enhances our understanding of allergens but also paves the way for safer treatment options for allergy sufferers. With three patents under her belt, Sabine continues to be a noteworthy figure in medical research and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…